Conny Gysemans

6PUBLICATIONS
23CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityMajor global burdens of diseaseAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 18, 2026
GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection.

|Nov 19, 2025
Redosing of anti-CD3 antibodies in NOD mice with new-onset diabetes does not alter the effect of a single treatment course.

Amber Wouters, Pierre Lemaitre, Laure Degroote

|Jul 12, 2025
Verapamil and low-dose anti-mouse thymocyte globulin combination therapy stably reverses recent-onset type 1 diabetes in NOD mice by acting on the beta cell and immune axes.

Laure Degroote, Pieter-Jan Martens, Marijke Viaene

|Mar 28, 2025
Exploring Neutrophil Heterogeneity and Plasticity in Health and Disease.

Conny Gysemans, Mateson Beya, Erika Pedace

|Jun 28, 2023
High-Throughput Analysis of Neutrophil Extracellular Trap Levels in Subtypes of People with Type 1 Diabetes.

Samal Bissenova, Mijke Buitinga, Markus Boesch

|May 13, 2023
NET Proteome in Established Type 1 Diabetes Is Enriched in Metabolic Proteins.

Samal Bissenova, Darcy Ellis, Aïsha Callebaut

Pageof 1

Frequent Collaborators

3 joint publications

Laure Degroote

3 joint publications

Chantal Mathieu

2 joint publications

Samal Bissenova

2 joint publications

Marc Packbier